Categories: All postsAnalysts

Descartes Systems Group still not a buy, Haywood says

Descartes CEO Ed Ryan.

Higher multiples for its peer group make him a little more bullish on Descartes Systems Group (Descartes System Group Stock Quote, Chart, News: TSX:DSG, Nasdaq:DSGX), but not enough for Haywood analyst Pardeep Sangha to recommend the stock.

In a research update to clients today, Sangha maintained his “Hold” rating on Descartes, but raised his one-year price target on the stock from (U.S.) $29.00 to $32.00, implying a return of 3.1 per cent at the time of publication.

On Wednesday, Descartes will report its Q3, 2018 results. Sangha expects the company will generate EBITDA of $21.0-million on revenue of $60.7-million, slightly better than the consensus of $20.4-million in EBITDA on a topline of $60.0-million.

Sangha explained the reasons for his price target raise.

“Descartes’ peer group valuation multiples have increased since our last report,” the analyst notes. “The Supply Chain industry peers currently trade at 27.3x EV/EBITDA, while the Canadian Software peers trade at 19.6x EV/EBITDA of consensus CY18 estimates (current average of the two groups is 23.5x EV/EBITDA vs. previous average of 18.0x EV/EBITDA). Descartes is currently trading at 24.5x EV/EBITDA of our CY18 estimates. Our new target price is based on a 25.0x EV/EBITDA multiple of our FY19 estimates compared to our previous target price based on a 22.7x EV/EBITDA multiple. We believe Descartes’ high valuation is justified by its industry leading EBITDA margins and strong revenue visibility.”

Sangha thinks Descartes will generate Adjusted EBITDA of (U.S.) 81.4-million on revenue of $234.4-million in fiscal 2018. He expects those numbers will improve to EBITDA of $96.7-million on a topline of $268.1-million the following year.

Tagged with: dsg
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

12 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

12 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

12 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

13 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

13 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

13 hours ago